Description
GLP-1 – SEMA 30 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
This listing is not an MHRA-licensed medicine.
Research-grade synthetic peptide supplied as a 30 mg sealed vial for lawful laboratory research in the UK. Catalogue name on the label: GLP-1 – SEMA. Not a food, supplement or medical device. Not for diagnostic or therapeutic use. Must not be administered to people or animals.
Licensed semaglutide products are prescription-only medicines. This vial is not those products.
Identification
| Catalogue name | GLP-1 – SEMA |
| Also listed as | Sema; GLP-1 (catalogue slang only) |
| Research identity | Semaglutide |
| Supplier | Opti-Gen Peptides |
| Contents | 30 mg per vial |
| CAS | 910463-68-2 |
| Class | Synthetic GLP-1 receptor analogue |
| Intended use | Laboratory / in-vitro research only |
Not Ozempic. Not Wegovy. Not Rybelsus. Not tirzepatide. Not retatrutide.
Quality / storage
Only the lot COA applies. Store as a laboratory peptide under institutional SOP. No reconstitution, pen-loading or injection instructions on this page.
Published research context (not product claims)
Semaglutide is described in literature as a GLP-1 receptor analogue. Receptor papers characterise GLP-1R pharmacology in experimental systems.
Clinical-development programmes produced authorised medicines. SUSTAIN / STEP-type papers concern licensed presentations. They must not be rewritten as weight-loss or diabetes claims for this vial.
There is no authorisation to market this vial as a UK medicine.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.
Reviews
There are no reviews yet.